Characteristics of sars-coV-2 and covid-19

395, 497–506 (2020).
www.nature.com/nrmicro
R e v i e w s
152 | march 2021 | volume 19 

---

61
. Mehta, P. et al. COVID-19: consider cytokine storm 
syndromes and immunosuppression. Lancet 395, 
1033–1034 (2020).
62
. Wu, C. et al. Risk factors associated with acute 
respiratory distress syndrome and death in patients 
with Coronavirus disease 2019 pneumonia in Wuhan, 
China. JAMA Intern. Med. 180, 934–943 (2020).
63
. Liu, Y. et al. Association between age and clinical 
characteristics and outcomes of COVID-19.
Eur. Respir. J.
55, 2001112 (2020).
64
. Tian, J. et al. Clinical characteristics and risk
factors associated with COVID-19 disease severity in 
patients with cancer in Wuhan, China: a multicentre, 
retrospective, cohort study. Lancet Oncol. 21,
893–903 (2020).
65
. Yao, X. H. et al. [A pathological report of three
COVID-19 cases by minimal invasive autopsies]. 
Zhonghua Bing Li Xue Za Zhi
49, 411–417 (2020).
66
. Martines, R. B. et al. Pathology and pathogenesis of 
SARS- CoV-2 associated with fatal coronavirus disease, 
United States. Emerg. Infect. Dis. 26, 2005–2015 
(2020).
67
. Zeng, Z. et al. Pulmonary pathology of early phase 
COVID-19 pneumonia in a patient with a Benign
lung lesion. Histopathology 
https://doi.org/10.1111/
his.14138
(2020).
68
. Sun, S. H. et al. A mouse model of SARS- CoV-2 
infection and pathogenesis. Cell Host Microbe 28, 
124–133 (2020).
69
. Rockx, B. et al. Comparative pathogenesis of COVID-19, 
MERS, and SARS in a nonhuman primate model. 
Science